Hetero is one of India’s leading generic
pharmaceutical companies and is one of the world’s largest producer of
anti-retroviral drugs for the treatment of HIV/AIDS. With more than 20 years of
expertise in the pharmaceutical industry, Hetero’s strategic business areas
include APIs, generics and biosimilars. Hetero also offers custom
pharmaceutical services to its partners around the world. The company is
recognized for its strengths in Research and Development, manufacturing and
commercialization of a wide range of products.
Hetero has more than 25 state-of-the-art
manufacturing facilities strategically located worldwide. Majority of our
facilities have been successfully audited and approved by stringent regulatory
authorities like US FDA, EU, TGA-Australia, MCC-South Africa and others. Our
portfolio includes more than 200 products, encompassing major therapeutic
categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis,
etc.
Hetero has a strong global presence in over 120
countries and focusses on making affordable medicines accessible to patients
worldwide
No comments:
Post a Comment